Advances in deep learning for drug discovery and biomarker development published in top journal

(InSilico Medicine, Inc.) Insilico Medicine, one of the industry leaders bridging deep learning for biology, chemistry and digital medicine, announced the publication of a special issue dedicated to 'Deep Learing for Drug Discovery and Biomarker Development' in one of the top industry journals celebrating its 15th anniversary published by the American Chemical Society, Molecular Pharmaceutics. The special issue starts with an article by the founder and CEO of Insilico Medicine, Alex Zhavoronkov, PhD, titled " Artificial Intelligence for Drug Discovery, Biomarker Development, and Generation of Novel Chemistry " .
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news